Detalhe da pesquisa
1.
Avelumab treatment in Italian patients with metastatic Merkel cell carcinoma: experience from an expanded access program.
J Transl Med
; 19(1): 70, 2021 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33588870
2.
Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence.
J Cell Physiol
; 235(11): 7900-7910, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31943171
3.
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting.
Int J Cancer
; 146(7): 1917-1929, 2020 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31330065
4.
Predictive Impact of Mucinous Tumors on the Clinical Outcome in Patients with Poorly Differentiated, Stage II Colon Cancer: A TOSCA Subgroup Analysis.
Oncologist
; 25(6): e928-e935, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31943506
5.
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience.
J Cell Physiol
; 234(6): 7708-7717, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30536609
6.
Phase III study with FOLFIRI + cetuximab versus FOLFIRI + cetuximab followed by cetuximab alone in RAS and BRAF WT mCRC.
Future Oncol
; 14(14): 1339-1346, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29846100
7.
Predictive Role of ERCC1 Expression in Head and Neck Squamous Cell Carcinoma Patients Treated with Surgery and Adjuvant Cisplatin-Based Chemoradiation.
Oncology
; 89(4): 227-34, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26066774
8.
Management of Esophago-Gastric Junction Carcinoma: A Narrative Multidisciplinary Review.
Cancers (Basel)
; 15(9)2023 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37174063
9.
Role of radiomics in predicting lymph node metastasis in gastric cancer: a systematic review.
Front Med (Lausanne)
; 10: 1189740, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37663653
10.
Extensive molecular profiling of squamous cell anal carcinoma in a phase 2 trial population: Translational analyses of the "CARACAS" study.
Eur J Cancer
; 182: 87-97, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36753836
11.
Treatment Settings and Outcomes with Regorafenib and Trifluridine/Tipiracil at Third-Line Treatment and beyond in Metastatic Colorectal Cancer: A Real-World Multicenter Retrospective Study.
Curr Oncol
; 30(6): 5456-5469, 2023 06 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37366896
12.
Retrospective Correlation between First Drug Treatment Duration and Survival Outcomes in Sequential Treatment with Regorafenib and Trifluridine/Tipiracil in Refractory Metastatic Colorectal Cancer: A Real-World Subgroup Analysis.
Cancers (Basel)
; 15(24)2023 Dec 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38136304
13.
Reduced-dose of doublet chemotherapy combined with anti-EGFR antibodies in vulnerable older patients with metastatic colorectal cancer: Data from the REVOLT study.
J Geriatr Oncol
; 13(3): 302-307, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34716122
14.
"OPERATION PHALCO"-Adapted Physical Activity for Breast Cancer Survivors: Is It Time for a Multidisciplinary Approach?
Cancers (Basel)
; 15(1)2022 Dec 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36612031
15.
Effectiveness of a phone-based nurse monitoring assessment and intervention for chemotherapy-related toxicity: A randomized multicenter trial.
Front Oncol
; 12: 925366, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36185306
16.
Oxaliplatin plus fluoropyrimidines as adjuvant therapy for colon cancer in older patients: A subgroup analysis from the TOSCA trial.
Eur J Cancer
; 148: 190-201, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33744715
17.
Randomized phase II trial of avelumab alone or in combination with cetuximab for patients with previously treated, locally advanced, or metastatic squamous cell anal carcinoma: the CARACAS study.
J Immunother Cancer
; 9(11)2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34815354
18.
The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial.
Sci Rep
; 11(1): 13770, 2021 07 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34215766
19.
PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting.
Ther Adv Med Oncol
; 13: 17588359211059873, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-35173816
20.
Clinical Practice Guidelines for Diagnosis, Treatment and Follow-Up of Exocrine Pancreatic Ductal Adenocarcinoma: Evidence Evaluation and Recommendations by the Italian Association of Medical Oncology (AIOM).
Cancers (Basel)
; 12(6)2020 Jun 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-32599886